Small Molecule repaglinide

Name repaglinide
Connectivity 24
Owner Public
URN urn:agi-cas:135062-02-1

ChemIDplus ID 135062021

CAS ID 135062-02-1

LinkUrl http://pubchem.ncbi.nlm.nih.gov/summary/summary.cgi?cid=65981

Source ChemIDplus

Alias (+)-2-Ethoxy-alpha-(((S)-alpha-isobutyl-o-piperidinobenzyl)carbamoyl)-p-toluic acid
(S)-2-ethoxy-4-(2-((3-methyl-1-(2-(1-piperidinyl)-phenyl)butyl)amino)-2-oxoethyl)-benzoic acid
AG-EE 388
AG-EE 388 ZW
AG-EE 623 ZW
Benzoic acid, 2-ethoxy-4-(2-((3-methyl-1-(2-(1-piperidinyl)phenyl)butyl)amino)-2-oxoethyl)-, (S)-
NovoNorm
Prandin
Repaglinida
Repaglinide
repaglinide, (+-)-isomer
Repaglinidum
ag-ee 623zw
benzoic acid, 2-ethoxy-4-(2-((3-methyl-1-(2-(1-piperidinyl)phenyl)butyl)amino)-2-oxoethy l)-, (s)
2-ethoxy-4-[[3-methyl-1-[2-(1-piperidyl)phenyl]-butyl]carbamoylmethyl]benzoic acid
Repaglinide [USAN]
[14C]-Repaglinide
[(18)F]repaglinide
[(3)H]repaglinide
(S)-()-2-Ethoxy-4-[N-[1-(2-piperidinophenyl)-3-methyl-1-butyl]aminocarbonylmethyl]benzoic acid
(S)-(+)-2-Ethoxy-4-[N-[1-(2-piperidinophenyl)-3-methyl-1-butyl]aminocarbonylmethyl]benzoic acid
135062-02-1
Repaglinida [INN-Spanish]
Repaglinidum [INN-Latin]

PubChem SID 208038

PubChem CID 65981

Pathway anti-diabetic drug pathway
potassium channel inhibitors pharmacodynamics pathway
repaglinide pharmacokinetics pathway
repaglinide pharmacokinetics pathway